Biomedical Engineering Reference
In-Depth Information
Guzman, M. L., Swiderski, C. F., Howard, D. S., Grimes, B. A., Rossi, R. M., Szilvassy, S. J.
and Jordan, C. T. 2002. Preferential induction of apoptosis for primary human leukemic
stem cells. Proc Natl Acad Sci USA 99:16220-5.
Guzman, M. L., Rossi, R. M., Karnischky, L., Li, X., Peterson, D. R., Howard, D. S. and
Jordan, C. T. 2005. The sesquiterpene lactone parthenolide induces apoptosis of human
acute myelogenous leukemia stem and progenitor cells. Blood 105:4163-9.
Guzman, M. L., Li, X., Corbett, C. A., Rossi, R. M., Bushnell, T., Liesveld, J. L., Hebert, J.,
Young, F. and Jordan, C. T. 2007a. Rapid and selective death of leukemia stem and
progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5
dione (TDZD-8). Blood 110:4436-44.
Guzman, M. L., Rossi, R. M., Neelakantan, S., Li, X., Corbett, C. A., Hassane, D. C., Becker,
M. W., Bennett, J. M., Sullivan, E., Lachowicz, J. L., Vaughan, A., Sweeney, C. J.,
Matthews, W., Carroll, M., Liesveld, J. L., Crooks, P. A. and Jordan, C. T. 2007b. An
orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia
stem and progenitor cells. Blood 110:4427-35.
Hamblin, T. J., Davis, Z., Gardiner, A., Oscier, D. G. and Stevenson, F. K. 1999. Unmutated
Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leuke-
mia. Blood 94:1848-54.
Hatano, M., Roberts, C. W., Minden, M., Crist, W. M. and Korsmeyer, S. J. 1991. Dereg-
ulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. Science 253:79-82.
Hogge, D. E., Lansdorp, P. M., Reid, D., Gerhard, B. and Eaves, C. J. 1996. Enhanced
detection, maintenance, and differentiation of primitive human hematopoietic cells in
cultures containing murine fibroblasts engineered to produce human steel factor, inter-
leukin-3, and granulocyte colony-stimulating factor. Blood 88:3765-73.
Holyoake, T., Jiang, X., Eaves, C. and Eaves, A. 1999a. Isolation of a highly quiescent
subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood 94:2056-64.
Holyoake, T. L., Nicolini, F. E. and Eaves, C. J. 1999b. Functional differences between
transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult
marrow. Exp Hematol 27:1418-27.
Holyoake, T. L., Jiang, X., Jorgensen, H. G., Graham, S., Alcorn, M. J., Laird, C., Eaves, A. C.
and Eaves, C. J. 2001. Primitive quiescent leukemic cells from patients with chronic myeloid
leukemia spontaneously initiate factor-independent growth in vitro in association with up-
regulation of expression of interleukin-3. Blood 97:720-8.
Hong, D., Gupta, R., Ancliff, P., Atzberger, A., Brown, J., Soneji, S., Green, J., Colman, S.,
Piacibello, W., Buckle, V., Tsuzuki, S., Greaves, M. and Enver, T. 2008. Initiating and
cancer-propagating cells
in TEL-AML1-associated childhood leukemia. Science
319:336-9.
Hope, K. J., Jin, L. and Dick, J. E. 2004. Acute myeloid leukemia originates from a hierarchy
of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 5:738-43.
Hosen, N., Park, C. Y., Tatsumi, N., Oji, Y., Sugiyama, H., Gramatzki, M., Krensky, A. M.
and Weissman, I. L. 2007. CD96 is a leukemic stem cell-specific marker in human acute
myeloid leukemia. Proc Natl Acad Sci USA 104:11008-13.
Hughes, T. P., Kaeda, J., Branford, S., Rudzki, Z., Hochhaus, A., Hensley, M. L., Gathmann, I.,
Bolton, A. E., van Hoomissen, I. C., Goldman, J. M. and Radich, J. P. 2003. Frequency of
major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed
chronic myeloid leukemia. N Engl J Med 349:1423-32.
Huntly, B. J., Shigematsu, H., Deguchi, K., Lee, B. H., Mizuno, S., Duclos, N., Rowan, R.,
Amaral, S., Curley, D., Williams, I. R., Akashi, K. and Gilliland, D. G. 2004. MOZ-TIF2,
but not BCR-ABL, confers properties of leukemic stem cells to committed murine hema-
topoietic progenitors. Cancer Cell 6:587-96.
Iscove, N. 1990. Haematopoiesis. Searching for stem cells. Nature 347:126-7.
Jamieson, C. H., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J.,
Li, K., Manz, M. G., Keating, A., Sawyers, C. L. and Weissman, I. L. 2004. Granulocyte-
